FI110668B - Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn - Google Patents
Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn Download PDFInfo
- Publication number
- FI110668B FI110668B FI20001460A FI20001460A FI110668B FI 110668 B FI110668 B FI 110668B FI 20001460 A FI20001460 A FI 20001460A FI 20001460 A FI20001460 A FI 20001460A FI 110668 B FI110668 B FI 110668B
- Authority
- FI
- Finland
- Prior art keywords
- atopic
- months
- children
- use according
- probiotic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/853—Lactobacillus
- Y10S435/856—Lactobacillus casei
Priority Applications (16)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20001460A FI110668B (fi) | 2000-06-20 | 2000-06-20 | Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn |
PT91642843T PT2201955T (pt) | 2000-06-20 | 2001-06-20 | Bifidobacterium lactis bb-12 na prevenção primária de doenças atópicas |
AT01951716T ATE439138T1 (de) | 2000-06-20 | 2001-06-20 | Probiotika zur primären prävention atopischer erkrankungen |
ES01951716T ES2329549T3 (es) | 2000-06-20 | 2001-06-20 | Probioticos para la prevencion primaria de enfermedades atopicas. |
ES09164284T ES2754797T3 (es) | 2000-06-20 | 2001-06-20 | Bifidobacterium lactis Bb-12 en prevención primaria de enfermedades atópicas |
ES09164285T ES2721848T3 (es) | 2000-06-20 | 2001-06-20 | Probióticos para su uso en la prevención primaria de enfermedades atópicas |
PCT/FI2001/000588 WO2001097822A1 (fr) | 2000-06-20 | 2001-06-20 | Probiotiques pour la prevention primaire de maladies atopiques |
EP09164285.0A EP2206507B1 (fr) | 2000-06-20 | 2001-06-20 | Probiotiques et leur utilisation pour la prévention principale des maladies atopiques |
EP09164284.3A EP2201955B1 (fr) | 2000-06-20 | 2001-06-20 | Bifidobacterium lactis Bb-12 pour la prévention principale des maladies atopiques |
PT01951716T PT1296694E (pt) | 2000-06-20 | 2001-06-20 | Probióticos na prevenção primária de doenças atópicas |
DE60139554T DE60139554D1 (de) | 2000-06-20 | 2001-06-20 | Probiotika zur primären prävention atopischer erkrankungen |
EP01951716A EP1296694B1 (fr) | 2000-06-20 | 2001-06-20 | Probiotiques pour la prevention primaire de maladies atopiques |
US10/311,706 US7112322B2 (en) | 2000-06-20 | 2001-06-20 | Probiotics in primary prevention of atopic diseases |
DE01951716T DE01951716T1 (de) | 2000-06-20 | 2001-06-20 | Probiotika zur primären prävention atopischer erkrankungen |
AU72572/01A AU784921B2 (en) | 2000-06-20 | 2001-06-20 | Probiotics in primary prevention of atopic diseases |
US11/225,204 US7988960B2 (en) | 2000-06-20 | 2005-09-14 | Probiotics in primary prevention of atopic diseases |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20001460A FI110668B (fi) | 2000-06-20 | 2000-06-20 | Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn |
FI20001460 | 2000-06-20 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI20001460A0 FI20001460A0 (fi) | 2000-06-20 |
FI20001460A FI20001460A (fi) | 2001-12-21 |
FI110668B true FI110668B (fi) | 2003-03-14 |
Family
ID=8558595
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI20001460A FI110668B (fi) | 2000-06-20 | 2000-06-20 | Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn |
Country Status (9)
Country | Link |
---|---|
US (2) | US7112322B2 (fr) |
EP (3) | EP1296694B1 (fr) |
AT (1) | ATE439138T1 (fr) |
AU (1) | AU784921B2 (fr) |
DE (2) | DE60139554D1 (fr) |
ES (3) | ES2329549T3 (fr) |
FI (1) | FI110668B (fr) |
PT (2) | PT1296694E (fr) |
WO (1) | WO2001097822A1 (fr) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1364586A1 (fr) * | 2002-05-24 | 2003-11-26 | Nestec S.A. | Produits probiotiques et tolérance orale |
JP4212838B2 (ja) * | 2002-06-26 | 2009-01-21 | カルピス株式会社 | 抗アレルギー剤 |
US20090257993A1 (en) | 2003-12-17 | 2009-10-15 | M Rabet Laura | Lactic Acid Producing Bacteria and Lung Function |
US7955834B2 (en) | 2004-06-03 | 2011-06-07 | Biogaia Ab | Method for improved breast milk feeding to reduce the risk of allergy |
US7862808B2 (en) | 2004-07-01 | 2011-01-04 | Mead Johnson Nutrition Company | Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12 |
EP1731137A1 (fr) * | 2005-06-08 | 2006-12-13 | Nestec S.A. | Composition cosmétique ou dermatologique pour peaux sèches et/ou sensibles |
MX2007004135A (es) * | 2004-10-04 | 2007-06-15 | Oreal | Composicion cosmetica y/o dermatologica para pieles sensibles. |
FR2876029B1 (fr) * | 2004-10-04 | 2008-11-14 | Oreal | Composition cosmetique et/ou dermatologique pour peaux sensibles. |
EP1642570A1 (fr) | 2004-10-04 | 2006-04-05 | L'oreal | Composition cosmétique et/ou dermatologique pour peaux sensibles |
ITMI20042189A1 (it) | 2004-11-16 | 2005-02-16 | Anidral Srl | Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale |
RU2270248C1 (ru) * | 2004-12-31 | 2006-02-20 | Открытое акционерное общество "Лианозовский молочный комбинат" | Штамм бифидобактерий bifidobacterium lactis 668, используемый для приготовления кисломолочных, ферментированных и неферментированных пищевых продуктов, биологически активных добавок, бактериальных препаратов и косметических средств |
US7303745B2 (en) | 2005-04-15 | 2007-12-04 | Bristol-Myers Squibb Company | Method for preventing or treating the development of respiratory allergies |
US20060233762A1 (en) * | 2005-04-15 | 2006-10-19 | Mcmahon Robert J | Method for treating or preventing systemic inflammation in formula-fed infants |
EP2264164A1 (fr) | 2005-05-11 | 2010-12-22 | Chr. Hansen A/S | Souches de bactéries lactiques sensitives aux antibiotiques |
JP2009067679A (ja) * | 2005-12-27 | 2009-04-02 | Univ Of Tokushima | 抗ヒスタミン作用を有する医薬 |
CA2883256A1 (fr) | 2006-03-10 | 2007-09-20 | N.V. Nutricia | Utilisation de saccharides non digestibles pour renforcer le systeme immunitaire |
EP2084276A1 (fr) | 2006-11-15 | 2009-08-05 | Chr. Hansen A/S | Nouvelles souches de bifidobactéries sensibles à la tétracycline |
US20100092429A1 (en) | 2006-12-11 | 2010-04-15 | Danisco A/S | Composition |
KR20100014523A (ko) * | 2007-02-22 | 2010-02-10 | 위르겐 슈레첸메이르 | 인간의 알레르기 반응을 예방, 억제 또는 제거하는 프로바이오틱 그램-양성 박테리아 |
EP1974743A1 (fr) * | 2007-03-28 | 2008-10-01 | Nestec S.A. | Probiotiques pour l'amélioration du microbiote intestinal |
CN101273737B (zh) * | 2007-03-28 | 2011-08-24 | 哈尔滨正方科技有限公司 | 一种在常温下保持高活菌数的发酵乳饮料的制备方法 |
EP1974734A1 (fr) * | 2007-03-28 | 2008-10-01 | Nestec S.A. | Probiotiques pour la réduction du risque d'obésité |
US20090007924A1 (en) * | 2007-04-30 | 2009-01-08 | Iliff Edwin C | Arbiter system and method of computerized medical diagnosis and advice |
FR2920305B1 (fr) | 2007-09-04 | 2010-07-30 | Oreal | Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles. |
FR2920304B1 (fr) | 2007-09-04 | 2010-06-25 | Oreal | Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse. |
EP2668854B1 (fr) | 2008-03-28 | 2015-07-01 | Nestec S.A. | Probiotiques à utiliser chez des femelles de mammifères gestantes pour renforcer l'immunité de leur progéniture |
US20110053889A1 (en) * | 2008-09-02 | 2011-03-03 | Joanne Szabo | Prenatal and postnatal screening and treatment of critical monosaccharide deficiencies for neurologic and immunologic function |
FR2942719B1 (fr) | 2009-03-04 | 2011-08-19 | Oreal | Utilisation de microorganismes probiotiques pour limiter les irritations cutanees |
WO2011044516A2 (fr) * | 2009-10-09 | 2011-04-14 | Prothera, Inc. | Compositions et procédés comprenant le pédiocoque pour réduire au moins un symptôme associé au trouble envahissant du développement chez une personne pour laquelle un trouble envahissant du développement a été diagnostiqué |
CN102269858A (zh) | 2010-06-02 | 2011-12-07 | 北京智朗芯光科技有限公司 | 自动聚焦系统和自动聚焦方法 |
KR101850165B1 (ko) * | 2010-06-30 | 2018-04-18 | 네스텍 소시에테아노님 | 피부 색소침착 조절용 식품 보충제에 있어서 카프타르산 및 락틱 박테리아의 용도 |
US9539269B2 (en) | 2010-12-31 | 2017-01-10 | Abbott Laboratories | Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides |
SG191394A1 (en) | 2010-12-31 | 2013-08-30 | Abbott Lab | Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents |
EE05750B1 (et) | 2011-02-25 | 2015-06-15 | OÜ Tervisliku Piima Biotehnoloogiate Arenduskeskus | Isoleeritud mikroorganismi tüvi Lactobacillus gasseri MCC2 DSM 23882 ning selle kasutamine |
EP2510932A1 (fr) | 2011-04-15 | 2012-10-17 | Nestec S.A. | Lactobacillus paracasei NCC2461 (ST11) à utiliser par administration maternelle périnatale dans la réduction et la prévention des allergies chez la descendance |
WO2012177556A2 (fr) | 2011-06-20 | 2012-12-27 | H.J. Heinz Company | Méthodes et compositions probiotiques |
ES2657744T3 (es) | 2011-07-22 | 2018-03-06 | Abbott Laboratories | Galactoligosacáridos para prevenir lesiones y/o promover la curación del tracto gastrointestinal |
EP2750523A1 (fr) | 2011-08-29 | 2014-07-09 | Abbott Laboratories | Oligosaccharides de lait humain pour prévenir une lésion et/ou activer la guérison du tractus gastro-intestinal |
EP2617296A1 (fr) * | 2012-01-19 | 2013-07-24 | Nestec S.A. | Composition comportant des souches de lactobacillus helveticus spécifiques et réduction des symptômes d'allergie d'aliments et/ou des symptômes d'allergie respiratoire |
EP2836224A4 (fr) | 2012-02-29 | 2015-12-16 | Ethicon Endo Surgery Inc | Compositions de microbiota et leurs procédés associés |
DK2861242T3 (en) | 2012-06-18 | 2018-10-29 | Heinz Co Brands H J Llc | GLUTEN RELATED DISORDERS |
WO2014052438A1 (fr) | 2012-09-25 | 2014-04-03 | Regents Of The University Of Minnesota | Procédé de production et d'utilisation de peptides antimicrobiens |
EP2994150B1 (fr) | 2013-05-10 | 2019-03-06 | H.J. Heinz Company Brands Llc | Probiotiques et procédés d'utilisation |
US20150064304A1 (en) * | 2013-09-03 | 2015-03-05 | Mario Medri | Probiotic lozenge, method of making same, and uses thereof |
WO2015071131A1 (fr) * | 2013-11-15 | 2015-05-21 | Nestec S.A. | Composition pour la prévention ou le traitement d'allergies chez des nourrissons d'une mère non sécrétrice ou nourris par une mère non sécrétrice par l'utilisation d'oligosaccharides fucosylés en particulier chez des enfants présentant un risque ou nés par césarienne |
WO2015090349A1 (fr) | 2013-12-16 | 2015-06-25 | Nestec S.A. | Intervention nutritionnelle à base de probiotiques pendant la grossesse, et éventuellement pendant l'allaitement, pour réduire le risque d'allergie chez le jeune enfant |
EP2886660A1 (fr) * | 2013-12-20 | 2015-06-24 | Rigas Tehniska universitate | Procédé d'hybridation fluorescente in situ pour l'identification d'un micro-organisme |
JP6868562B2 (ja) | 2014-10-31 | 2021-05-19 | ペンデュラム セラピューティクス, インコーポレイテッド | 障害の微生物的処置および診断に関する方法および組成物 |
WO2016149687A1 (fr) * | 2015-03-18 | 2016-09-22 | Whole Biome, Inc. | Méthodes et compositions se rapportant à un traitement microbien et au diagnostic de troubles cutanés |
CA2950839C (fr) * | 2016-01-30 | 2023-09-12 | Cooper Technologies Company | Support d'equipement et composantes associees |
WO2019046646A1 (fr) | 2017-08-30 | 2019-03-07 | Whole Biome Inc. | Methodes et compositions pour le traitement de troubles associés au microbiome |
EP3897678A1 (fr) * | 2018-12-21 | 2021-10-27 | Société des Produits Nestlé S.A. | Combinaison probiotique pour le traitement de troubles allergiques |
WO2021138599A1 (fr) * | 2020-01-03 | 2021-07-08 | Forte Subsidiary, Inc. | Compositions cosmétiques |
EP4251183A1 (fr) * | 2020-11-24 | 2023-10-04 | Johnson & Johnson Consumer Inc. | Procédés de prévention, de retardement ou d'amélioration de maladies atopiques |
WO2024042229A1 (fr) | 2022-08-25 | 2024-02-29 | Chr. Hansen A/S | Souches de bifidobacterium à stabilité améliorée |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5591446A (en) * | 1989-04-04 | 1997-01-07 | Beiersdorf, A.G. | Methods and agents for the prophylaxis of atopy |
US5246591A (en) * | 1990-07-13 | 1993-09-21 | Pact, Incorporated | Separation of metal ions on an anion exchange resin by chromatographic elution |
BE1009359A7 (fr) * | 1995-05-19 | 1997-02-04 | Univ Bruxelles | Procede de detection et/ou de quantification de ligands specifiques d'une pathologie liee a une reponse allergique. |
FI104465B (fi) | 1995-06-14 | 2000-02-15 | Valio Oy | Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö |
EP0904784A1 (fr) * | 1997-09-22 | 1999-03-31 | N.V. Nutricia | Préparation nutritionnelle probiotique |
GB9808579D0 (en) * | 1998-04-22 | 1998-06-24 | Novartis Nutrition Ag | Improvements in or relating to organic compounds |
JP4010062B2 (ja) * | 1998-09-02 | 2007-11-21 | 医療法人社団青藍会 | アトピー性皮膚炎を防ぐ保健食品 |
JP2000086524A (ja) | 1998-09-05 | 2000-03-28 | Shadan Seirankai | 生きた腸内細菌を含有する抗アレルギー剤 |
AUPQ415899A0 (en) * | 1999-11-19 | 1999-12-16 | Vasse Research Institute Pty Ltd | Compositions for and methods of treatment of allergic diseases |
-
2000
- 2000-06-20 FI FI20001460A patent/FI110668B/fi active
-
2001
- 2001-06-20 EP EP01951716A patent/EP1296694B1/fr not_active Expired - Lifetime
- 2001-06-20 ES ES01951716T patent/ES2329549T3/es not_active Expired - Lifetime
- 2001-06-20 WO PCT/FI2001/000588 patent/WO2001097822A1/fr active Application Filing
- 2001-06-20 AU AU72572/01A patent/AU784921B2/en not_active Expired
- 2001-06-20 DE DE60139554T patent/DE60139554D1/de not_active Expired - Lifetime
- 2001-06-20 AT AT01951716T patent/ATE439138T1/de not_active IP Right Cessation
- 2001-06-20 EP EP09164285.0A patent/EP2206507B1/fr not_active Expired - Lifetime
- 2001-06-20 EP EP09164284.3A patent/EP2201955B1/fr not_active Expired - Lifetime
- 2001-06-20 PT PT01951716T patent/PT1296694E/pt unknown
- 2001-06-20 ES ES09164285T patent/ES2721848T3/es not_active Expired - Lifetime
- 2001-06-20 DE DE01951716T patent/DE01951716T1/de active Pending
- 2001-06-20 ES ES09164284T patent/ES2754797T3/es not_active Expired - Lifetime
- 2001-06-20 PT PT91642843T patent/PT2201955T/pt unknown
- 2001-06-20 US US10/311,706 patent/US7112322B2/en not_active Expired - Lifetime
-
2005
- 2005-09-14 US US11/225,204 patent/US7988960B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2001097822A1 (fr) | 2001-12-27 |
EP1296694B1 (fr) | 2009-08-12 |
ATE439138T1 (de) | 2009-08-15 |
EP2201955A1 (fr) | 2010-06-30 |
US20030180272A1 (en) | 2003-09-25 |
AU7257201A (en) | 2002-01-02 |
US7988960B2 (en) | 2011-08-02 |
US7112322B2 (en) | 2006-09-26 |
PT2201955T (pt) | 2019-11-25 |
FI20001460A (fi) | 2001-12-21 |
EP2206507A1 (fr) | 2010-07-14 |
AU784921B2 (en) | 2006-07-27 |
ES2754797T3 (es) | 2020-04-20 |
US20060013806A1 (en) | 2006-01-19 |
PT1296694E (pt) | 2009-10-28 |
EP1296694A1 (fr) | 2003-04-02 |
EP2201955B1 (fr) | 2019-08-14 |
ES2329549T3 (es) | 2009-11-27 |
DE60139554D1 (de) | 2009-09-24 |
EP2206507B1 (fr) | 2019-03-13 |
ES2721848T3 (es) | 2019-08-05 |
DE01951716T1 (de) | 2005-06-23 |
FI20001460A0 (fi) | 2000-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI110668B (fi) | Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn | |
Dzidic et al. | Oral microbiota maturation during the first 7 years of life in relation to allergy development | |
JP5117171B2 (ja) | 抗アレルギーの乳酸菌 | |
Pedrosa et al. | Survival of yogurt-containing organisms and Lactobacillus gasseri (ADH) and their effect on bacterial enzyme activity in the gastrointestinal tract of healthy and hypochlorhydric elderly subjects | |
Kalliomäki et al. | Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing | |
Shadid et al. | Effects of galactooligosaccharide and long-chain fructooligosaccharide supplementation during pregnancy on maternal and neonatal microbiota and immunity—a randomized, double-blind, placebo-controlled study | |
Duffy et al. | Modulation of rotavirus enteritis during breast-feeding: implications on alterations in the intestinal bacterial flora | |
US9707258B2 (en) | Bioconversion of milk with Bifidobacterium breve for treatment of allergic manifestions in infants | |
BG107299A (bg) | Употреба на lactobacillus casei в имуностимулиращи пептиди | |
JP6985342B2 (ja) | ビフィドバクテリウム ラクティス gkk2、それを含む組成物、およびアレルギー性喘息改善のためのその使用 | |
JP2020523329A (ja) | バチルス・コアグランスの脂質低下効果 | |
JP2023037613A (ja) | 乳酸菌含有組成物 | |
US11723936B2 (en) | Therapeutic uses of Lactobacillus plantarum | |
CN101503662B (zh) | 用于抗过敏症状的微生物株、其组合物和以此微生物株刺激细胞产生干扰素-γ的方法 | |
Yamashita et al. | Intake safety of Lactobacillus helveticus SBT2171 and its effects on nasal and ocular symptoms associated with mites and house dust: An open-label study and a randomized, double-blind, placebo-controlled, parallel group study | |
CN111617061A (zh) | 一种亚精胺在制备提高毛螺菌属细菌丰度制剂中的应用 | |
Mosaddek | Effect of probiotics in the treatment of acute watery diarrhoea in children admitted to a tertiary care hospital in Bangladesh: a non-randomized prospective clinical trial | |
WO2021059241A1 (fr) | Compositions de microbiome et méthodes de traitement d'atopies | |
CN114990004B (zh) | 一种分泌型免疫球蛋白a包裹态罗伊氏乳杆菌及防治妊娠糖尿病的应用 | |
Chundakkattumalayil et al. | Health endorsing potential of Lactobacillus plantarum MBTU-HK1 and MBTU-HT of Honey bee gut origin | |
McDade et al. | Fetal Programming of Immune Function | |
Çalışır et al. | Evaluation of the effect of probiotics on celiac patients | |
Mosaddek et al. | Effect of Probiotics in Acute Watery Diarrhea in Children Admitted To a Bangladeshi Tertiary-Care Hospital: A Non-Randomized Prospective Clinical Trial | |
Elebeedy et al. | The Healing Effect of Probiotics on Indomethacin Induced Gastric Ulcer in Rats | |
Shabaan et al. | Study of Different Types of Gut Flora among Obese Egyptian Children |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RF | Appeal filed | ||
PC | Transfer of assignment of patent |
Owner name: NESTEC S.A. Free format text: NESTEC S.A. |
|
FCK | Appeal rejected |